Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. Amazon Location Service.

Clinical trial site

Tufts Medical Center

Tufts Medical Center in Boston, Massachusetts, United States is listed as a site for 812 registered clinical trials, 244 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 812
Ongoing 244

This page covers the site record Tufts Medical Center in Boston, Massachusetts, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Tufts Medical Center, also sponsors trials.

Get the Tufts Medical Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 812 trials counted.

  • Phase 1 41 trials
  • Phase 1/2 21 trials
  • Phase 2 193 trials
  • Phase 2/3 23 trials
  • Phase 3 235 trials
  • Phase 4 29 trials
  • Not applicable 158 trials
  • Observational 109 trials
  • Expanded access 3 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 244 trials
  • Completed 401 trials
  • Terminated 141 trials
  • Other 26 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 62

1993: 1 trials (Observational 1) 2000: 2 trials (Phase 3 2) 2002: 1 trials (Not applicable 1) 2003: 7 trials (Observational 1, Not applicable 2, Phase 3 2, Phase 2/3 2) 2004: 4 trials (Observational 2, Phase 3 1, Phase 1 1) 2005: 6 trials (Observational 2, Phase 3 3, Phase 2 1) 2006: 8 trials (Observational 1, Not applicable 1, Phase 3 5, Phase 1 1) 2007: 14 trials (Observational 2, Not applicable 4, Phase 4 1, Phase 3 5, Phase 2 2) 2008: 25 trials (Observational 1, Not applicable 4, Phase 4 2, Phase 3 9, Phase 2 9) 2009: 35 trials (Observational 3, Not applicable 5, Phase 4 1, Phase 3 15, Phase 2 7, Phase 1 4) 2010: 33 trials (Observational 5, Not applicable 5, Phase 4 2, Phase 3 10, Phase 2/3 1, Phase 2 5, Phase 1/2 3, Phase 1 2) 2011: 30 trials (Observational 3, Not applicable 3, Phase 4 5, Phase 3 9, Phase 2 6, Phase 1/2 1, Phase 1 3) 2012: 29 trials (Observational 2, Not applicable 6, Phase 4 1, Phase 3 9, Phase 2/3 1, Phase 2 9, Phase 1/2 1) 2013: 51 trials (Observational 8, Not applicable 8, Phase 4 1, Phase 3 11, Phase 2/3 1, Phase 2 17, Phase 1/2 1, Phase 1 4) 2014: 45 trials (Observational 9, Not applicable 8, Phase 4 2, Phase 3 7, Phase 2/3 3, Phase 2 12, Phase 1/2 2, Phase 1 2) 2015: 31 trials (Observational 5, Not applicable 8, Phase 4 1, Phase 3 6, Phase 2/3 1, Phase 2 8, Phase 1/2 1, Phase 1 1) 2016: 41 trials (Observational 7, Not applicable 6, Phase 4 3, Phase 3 10, Phase 2/3 1, Phase 2 13, Phase 1 1) 2017: 50 trials (Observational 8, Not applicable 12, Phase 4 5, Phase 3 13, Phase 2/3 2, Phase 2 6, Phase 1 4) 2018: 51 trials (Observational 3, Not applicable 11, Phase 3 16, Phase 2 16, Phase 1/2 1, Phase 1 4) 2019: 52 trials (Observational 8, Not applicable 7, Phase 3 23, Phase 2/3 2, Phase 2 9, Phase 1 3) 2020: 62 trials (Observational 10, Not applicable 12, Phase 4 1, Phase 3 19, Phase 2/3 2, Phase 2 15, Phase 1 3) 2021: 52 trials (Observational 4, Not applicable 13, Phase 4 2, Phase 3 14, Phase 2/3 2, Phase 2 11, Phase 1/2 2, Phase 1 4) 2022: 40 trials (Observational 3, Not applicable 11, Phase 4 2, Phase 3 6, Phase 2/3 3, Phase 2 10, Phase 1/2 2, Phase 1 3) 2023: 30 trials (Observational 7, Not applicable 5, Phase 3 8, Phase 2/3 1, Phase 2 8, Phase 1/2 1) 2024: 47 trials (Observational 5, Not applicable 10, Phase 3 11, Phase 2/3 1, Phase 2 15, Phase 1/2 5) 2025: 39 trials (Observational 3, Not applicable 11, Phase 3 13, Phase 2 11, Phase 1/2 1)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 22
2025 39
2024 47
2023 30
2022 40
2021 52
2020 62
2019 52
2018 51
2017 50

Showing 10 of 27 years.

Start your 14-day trial Email me all 27 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 812 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 208 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 427 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF